Literature DB >> 1082932

An analysis of the action of atropine and scopolamine on the end-plate current of frog sartorius muscle.

M Adler, E X Albuquerque.   

Abstract

The effects of atropine sulfate and scopolamine hydrobromide were investigated on the end-plate current (EPC) of frog sartorius muscle by standard voltage-clamp techniques. Both atropine and scopolamine reduced the peak EPC amplitude although scopolamine was only one-third as potent as atropine. The reduction of amplitude became more pronounced with increasing membrane hyperpolarization resulting in nonlinear current-voltage characteristics. Atropine shortened the EPC duration and decreased the voltage-sensitivity of the falling phase; the latter, however, continued to remain a single exponential function of time as in the control. Scopolamine reduced the time to peak, and in addition, converted the falling phase to a double exponential function, consisting of a rapid initial phase followed by a slow terminal phase. Both phases of fall were altered by changes in drug concentration but only the terminal phase responded appreciably to changes in membrane potential. Atropine and scopolamine were without effect on the EPC reversal potential, indicating that the drugs do not exhibit a preference for the ionic species carrying the synaptic current.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082932

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

1.  Perhydrohistrionicotoxin: a potential ligand for the ion conductance modulator of the acetylcholine receptor.

Authors:  A T Eldefrawi; M E Eldefrawi; E X Albuquerque; A C Oliveira; N Mansour; M Adler; J W Daly; G B Brown; W Burgermeister; B Witkop
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

2.  Nicotinic acetylcholine receptor-ion channels involved in synaptic currents in bullfrog sympathetic ganglion cells and effects of atropine.

Authors:  S Minota; T Eguchi; K Kuba
Journal:  Pflugers Arch       Date:  1989-07       Impact factor: 3.657

3.  The actions of tubocurarine at the frog neuromuscular junction.

Authors:  D Colquhoun; F Dreyer; R E Sheridan
Journal:  J Physiol       Date:  1979-08       Impact factor: 5.182

4.  Effects of McN-A-343, a cholinomimetic drug, on endplate currents in the frog.

Authors:  K Alkadhi; D D Branisteanu; E G Henderson; J J Lambert; R L Volle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

5.  The action of polymyxin B at the frog neuromuscular junction.

Authors:  N N Durant; J J Lambert
Journal:  Br J Pharmacol       Date:  1981-01       Impact factor: 8.739

6.  Analysis of atropine action at the frog neutromuscular junction.

Authors:  A Feltz; W A Large; A Trautmann
Journal:  J Physiol       Date:  1977-07       Impact factor: 5.182

Review 7.  Acetylcholine receptor kinetics.

Authors:  P R Adams
Journal:  J Membr Biol       Date:  1981-02-28       Impact factor: 1.843

8.  Tetraethylammonium: voltage-dependent action on endplate conductance and inhibition of ligand binding to postsynaptic proteins.

Authors:  M Adler; A C Oliveira; M E Eldefrawi; A T Eldefrawi; E X Albuquerque
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

9.  A quantitative analysis of local anaesthetic alteration of miniature end-plate currents and end-plate current fluctuations.

Authors:  R L Ruff
Journal:  J Physiol       Date:  1977-01       Impact factor: 5.182

10.  Elucidation of the mechanism and site of action of quinuclidinyl benzilate (QNB) on the electrical excitability and chemosensitivity of the frog sartorius muscle.

Authors:  G G Schofield; J E Warnick; E X Albuquerque
Journal:  Cell Mol Neurobiol       Date:  1981-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.